Abstract
In the originally published article, the average incidence rates of 0.41 per 1,000 person-years among the total cohort and 0.26 per 1,000 person-years among the subgroup in the Results section on page 4 were incorrectly reported as per 1,000 person-years, whereas the units should have been per 1,000 person-months. These errors do not affect the main results or conclusions of the paper. These corrections do not affect the description, interpretation, and conclusions of the manuscript. The authors apologize for this mistake.
| Original language | English |
|---|---|
| Pages (from-to) | 2145 |
| Number of pages | 1 |
| Journal | American Journal of Gastroenterology |
| Volume | 119 |
| Issue number | 10 |
| DOIs |
|
| State | Published - 01 10 2024 |
Bibliographical note
Publisher Copyright:© 2024 by The American College of Gastroenterology.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Humans
- Hepatitis B, Chronic/drug therapy
- Antiviral Agents/therapeutic use
- Incidence
- Liver Failure/epidemiology
- Withholding Treatment
- Nucleosides/therapeutic use
Fingerprint
Dive into the research topics of 'Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study) (Am J Gastroenterol (2023) DOI: 10.14309/ajg.0000000000002203)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver